Prophylaxis of fungal infections.
Considering the high morbidity and mortality of deep-seated opportunistic mycoses in severely immunosuppressed patients, strategies for prophylaxis appear to be indicated. Exposure to Aspergillus spp. can be prevented by air filtration which has been shown to reduce the rate of infection. However, Candida infections are predominantly caused by colonizing fungi; therefore drug prophylaxis is more promising. Prospective randomized studies proved the effectiveness of fluconazole (FLU) to prevent infections in patients after bone marrow transplantation.
Schuler
U S
US
Medizinische Klinik I, Universitätsklinikum Carl Gustav Carus, Technischen Universität Dresden, FR Germany.
Haag
C
C
D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000517:prevention & control; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002177:Candidiasis / Q000517:prevention & control; D015725:Fluconazole / Q000627:therapeutic use*; D016867:Immunocompromised Host; D009181:Mycoses / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic
D000935:Antifungal Agents; D015725:Fluconazole